Handel Assertio Holdings, Inc. - ASRT CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | 0.0486 | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.024874% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | 0.002651% | ||||||||
Gebyr natten over, tid | 21:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | USD | ||||||||
Margen | 20% | ||||||||
Aktiebørs | United States of America | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
Tidligere luk* | 6.3906 |
Åben* | 6.4404 |
1-Års Ændring* | 136.78% |
Dagens Spænd* | 6.2809 - 6.4504 |
52-Ugers Spænd | 1.86-7.00 |
Gennemsnitlig Volumen (10 dage) | 1.48M |
Gennemsnitlig Volumen (3 måneder) | 39.46M |
Market Cap | 356.26M |
P/E-forhold | 3.66 |
Udestående aktier | 55.58M |
Omsætning | 156.23M |
EPS | 1.75 |
Dividend (Udbytte %) | N/A |
Beta | 1.40 |
Næste indtjeningsopgørelse | May 8, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|---|---|---|---|---|---|
Mar 31, 2023 | 6.3507 | -0.0798 | -1.24% | 6.4305 | 6.4903 | 6.2610 |
Mar 30, 2023 | 6.3906 | 0.0898 | 1.43% | 6.3008 | 6.4504 | 6.3008 |
Mar 29, 2023 | 6.2710 | -0.1096 | -1.72% | 6.3806 | 6.4006 | 6.1314 |
Mar 28, 2023 | 6.2411 | 0.2892 | 4.86% | 5.9519 | 6.3408 | 5.9519 |
Mar 27, 2023 | 5.9619 | -0.0199 | -0.33% | 5.9818 | 6.1015 | 5.8921 |
Mar 24, 2023 | 5.8423 | 0.2493 | 4.46% | 5.5930 | 5.9519 | 5.5830 |
Mar 23, 2023 | 5.7625 | -0.1097 | -1.87% | 5.8722 | 6.0317 | 5.7326 |
Mar 22, 2023 | 5.7824 | -0.1595 | -2.68% | 5.9419 | 6.0915 | 5.7824 |
Mar 21, 2023 | 5.9120 | 0.1097 | 1.89% | 5.8023 | 6.0217 | 5.8023 |
Mar 20, 2023 | 5.7525 | -0.0299 | -0.52% | 5.7824 | 5.9320 | 5.7126 |
Mar 17, 2023 | 5.8024 | -0.3589 | -5.83% | 6.1613 | 6.1613 | 5.8024 |
Mar 16, 2023 | 6.2211 | 0.5783 | 10.25% | 5.6428 | 6.2909 | 5.5531 |
Mar 15, 2023 | 5.6528 | -0.0697 | -1.22% | 5.7225 | 5.8423 | 5.5731 |
Mar 14, 2023 | 5.8921 | 0.5484 | 10.26% | 5.3437 | 6.0516 | 5.3437 |
Mar 13, 2023 | 5.2241 | -0.3090 | -5.58% | 5.5331 | 5.5830 | 5.2141 |
Mar 10, 2023 | 5.7226 | -0.7676 | -11.83% | 6.4902 | 6.5402 | 5.6129 |
Mar 9, 2023 | 6.6399 | 0.6781 | 11.37% | 5.9618 | 6.9689 | 5.9418 |
Mar 8, 2023 | 5.9320 | -0.1794 | -2.94% | 6.1114 | 6.1414 | 5.7924 |
Mar 7, 2023 | 6.1414 | 0.1098 | 1.82% | 6.0316 | 6.2510 | 5.9020 |
Mar 6, 2023 | 6.0815 | -0.3589 | -5.57% | 6.4404 | 6.4504 | 6.0018 |
Assertio Holdings, Inc. Events
Tid (UTC) (UTC) | Land | Begivenhed |
---|---|---|
No events scheduled |
- Årlig
- Pr kvartal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total omsætning | 156.234 | 111.014 | 106.275 | 229.504 | 311.77 |
Omsætning | 156.234 | 111.014 | 106.275 | 229.504 | 311.77 |
Kost af omsætning, Total | 17.948 | 15.232 | 15.772 | 9.505 | 18.476 |
Bruttofortjeneste | 138.286 | 95.782 | 90.503 | 219.999 | 293.294 |
Totale Driftsudgifter | 116.829 | 101.59 | 132.637 | 397.547 | 206.111 |
Salgs/Generelle/Admin. Udgifter, Total | 45.986 | 56.555 | 105.323 | 108.866 | 119.218 |
Forskning & Udvikling | 0 | 4.213 | 10.106 | 8.042 | |
Depreciation / Amortization | 33.408 | 28.114 | 24.783 | 101.774 | 101.774 |
Usædvanlig Udgift (Indkomst) | 0.8 | 1.689 | -17.454 | 167.296 | -41.399 |
Driftsindtægter | 39.405 | 9.424 | -26.362 | -168.043 | 105.659 |
Renteindkomst (Udgift), Netto Ikke-Drift | -7.961 | -10.22 | -15.926 | -58.389 | -68.881 |
Andre, Netto | -0.278 | 0.243 | -3.225 | 3.948 | 1.197 |
Netto Indkomst Før Skat | 31.166 | -0.553 | -45.513 | -222.484 | 37.975 |
Netto Indkomst Efter Skat | 109.625 | -1.281 | -28.144 | -217.201 | 36.908 |
Netto Indkomst Før Ekstra Ting | 109.625 | -1.281 | -28.144 | -217.201 | 36.908 |
Netto Indkomst | 109.625 | -1.281 | -28.144 | -217.201 | 36.908 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 109.625 | -1.281 | -28.144 | -217.201 | 36.908 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 109.625 | -1.281 | -28.144 | -217.201 | 36.908 |
Fortyndelsesændring | |||||
Fortyndet Netto Indkomst | 109.625 | -1.281 | -28.144 | -217.201 | 36.908 |
Fortyndet Vægtet Gennemsnit Aktier | 54.669 | 43.169 | 26.2087 | 17.679 | 16.052 |
Fortyndet EPS Uden Ekstraordinære Ting | 2.00525 | -0.02967 | -1.07384 | -12.2858 | 2.29928 |
Fortyndet Normaliseret EPS | 2.01476 | -0.00424 | -1.50671 | -6.13488 | 0.62289 |
Totale Ekstraordinære Ting | |||||
Renteudgift (Indkomst) - Netto Drift | 18.687 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Total omsætning | 50.35 | 34.212 | 35.131 | 36.538 | 33.328 |
Omsætning | 50.35 | 34.212 | 35.131 | 36.538 | 33.328 |
Kost af omsætning, Total | 5.914 | 4.009 | 4.228 | 3.795 | 4.896 |
Bruttofortjeneste | 44.436 | 30.203 | 30.903 | 32.743 | 28.432 |
Totale Driftsudgifter | 39.728 | 27.778 | 24.34 | 24.979 | 25.347 |
Salgs/Generelle/Admin. Udgifter, Total | 13.502 | 11.7 | 10.343 | 10.438 | 13.276 |
Forskning & Udvikling | 0 | ||||
Depreciation / Amortization | 8.37 | 8.169 | 8.169 | 8.701 | 7.175 |
Usædvanlig Udgift (Indkomst) | 0.1 | 0 | 0.3 | 0.4 | 0 |
Driftsindtægter | 10.622 | 6.434 | 10.791 | 11.559 | 7.981 |
Renteindkomst (Udgift), Netto Ikke-Drift | -1.313 | -2.052 | -2.269 | -2.327 | -2.437 |
Andre, Netto | -0.731 | 0.002 | -0.095 | 0.545 | -0.504 |
Netto Indkomst Før Skat | 8.578 | 4.384 | 8.427 | 9.777 | 5.04 |
Netto Indkomst Efter Skat | 88.553 | 4.174 | 7.834 | 9.064 | 4.606 |
Netto Indkomst Før Ekstra Ting | 88.553 | 4.174 | 7.834 | 9.064 | 4.606 |
Netto Indkomst | 88.553 | 4.174 | 7.834 | 9.064 | 4.606 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 88.553 | 4.174 | 7.834 | 9.064 | 4.606 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 88.553 | 4.174 | 7.834 | 9.064 | 4.606 |
Fortyndet Netto Indkomst | 88.553 | 4.174 | 7.834 | 9.064 | 4.606 |
Fortyndet Vægtet Gennemsnit Aktier | 67.266 | 57.386 | 47.579 | 46.127 | 45.026 |
Fortyndet EPS Uden Ekstraordinære Ting | 1.31646 | 0.07274 | 0.16465 | 0.1965 | 0.1023 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Fortyndet Normaliseret EPS | 1.31743 | 0.07274 | 0.17051 | 0.20454 | 0.1023 |
Renteudgift (Indkomst) - Netto Drift | 11.842 | 3.9 | 1.3 | 1.645 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 103.498 | 94.254 | 103.951 | 208.107 | 230.851 |
Likvider og Kortsigtede Investeringer | 36.81 | 20.786 | 42.107 | 110.949 | 128.089 |
Likvider & Lignende | 36.81 | 20.786 | 42.107 | 110.949 | 126.884 |
Kortsigtede Investeringer | 0 | 1.205 | |||
Totale Tilgodehavender, Netto | 44.361 | 44.35 | 43.544 | 37.211 | 72.482 |
Accounts Receivable - Trade, Net | 44.361 | 44.35 | 43.257 | 37.211 | 72.482 |
Total Inventory | 7.489 | 11.712 | 3.412 | 3.396 | 13.042 |
Prepaid Expenses | 14.838 | 17.406 | 14.888 | 56.551 | 17.238 |
Total Assets | 326.547 | 303.274 | 527.17 | 932.866 | 1038.62 |
Property/Plant/Equipment, Total - Net | 2.262 | 4.784 | 6.273 | 13.064 | 13.024 |
Property/Plant/Equipment, Total - Gross | 14.011 | 15.57 | 18.143 | 23.837 | 26.945 |
Accumulated Depreciation, Total | -11.749 | -10.786 | -11.87 | -10.773 | -13.921 |
Intangibles, Net | 216.054 | 200.082 | 400.535 | 692.099 | 793.873 |
Other Long Term Assets, Total | 3.154 | 2.575 | 2.247 | 7.812 | 0.869 |
Total Current Liabilities | 135.019 | 132.686 | 184.553 | 246.036 | 310.58 |
Accounts Payable | 6.685 | 14.808 | 16.193 | 6.138 | 14.732 |
Accrued Expenses | 69.339 | 99.161 | 88.36 | 118.765 | 209.544 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 46.821 | 6.775 | 1.133 | 3.804 | |
Total Liabilities | 224.133 | 247.76 | 469.212 | 712.531 | 869.109 |
Total Long Term Debt | 61.319 | 72.16 | 271.258 | 446.107 | 544.23 |
Long Term Debt | 61.319 | 72.16 | 271.258 | 446.107 | 544.23 |
Other Liabilities, Total | 27.795 | 42.914 | 13.401 | 20.388 | 14.299 |
Total Equity | 102.414 | 55.514 | 57.958 | 220.335 | 169.508 |
Preferred Stock - Non Redeemable, Net | |||||
Common Stock | 0.004 | 0.013 | 0.008 | 0.006 | 0.006 |
Additional Paid-In Capital | 531.636 | 483.446 | 457.751 | 402.934 | 389.015 |
Retained Earnings (Accumulated Deficit) | -429.226 | -427.945 | -399.801 | -182.6 | -219.508 |
Other Equity, Total | 0 | -0.005 | -0.005 | ||
Total Liabilities & Shareholders’ Equity | 326.547 | 303.274 | 527.17 | 932.866 | 1038.62 |
Total Common Shares Outstanding | 44.6404 | 28.3922 | 20.222 | 16.0463 | 15.8501 |
Long Term Investments | 1.579 | 1.579 | 13.064 | 11.784 | 0 |
Current Port. of LT Debt/Capital Leases | 12.174 | 11.942 | 80 | 120 | 82.5 |
Note Receivable - Long Term | 1.1 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 125.115 | 103.498 | 112.545 | 119.348 | 124.069 |
Likvider og Kortsigtede Investeringer | 61.389 | 36.81 | 58.726 | 54.428 | 61.033 |
Likvider & Lignende | 61.389 | 36.81 | 58.726 | 54.428 | 61.033 |
Totale Tilgodehavender, Netto | 48.923 | 44.361 | 36.145 | 45.468 | 39.241 |
Accounts Receivable - Trade, Net | 48.923 | 44.361 | 36.145 | 45.368 | 38.915 |
Total Inventory | 9.48 | 7.489 | 5.481 | 6.617 | 8.93 |
Prepaid Expenses | 5.323 | 14.838 | 12.193 | 12.835 | 14.865 |
Total Assets | 339.135 | 326.547 | 299.305 | 312.016 | 325.424 |
Property/Plant/Equipment, Total - Net | 1.915 | 2.262 | 2.59 | 2.969 | 2.172 |
Property/Plant/Equipment, Total - Gross | 13.126 | 14.011 | 14.134 | 14.277 | 13.222 |
Accumulated Depreciation, Total | -11.211 | -11.749 | -11.544 | -11.308 | -11.05 |
Intangibles, Net | 207.554 | 216.054 | 179.143 | 186.318 | 193.536 |
Other Long Term Assets, Total | 2.972 | 3.154 | 3.448 | 1.802 | 5.647 |
Total Current Liabilities | 138.527 | 135.019 | 100.48 | 116.914 | 109.09 |
Accounts Payable | 8.523 | 6.685 | 7.666 | 16.483 | 10.609 |
Accrued Expenses | 72.175 | 69.339 | 64.057 | 72.058 | 76.743 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 12.271 | 12.174 | 12.257 | 12.222 | 12.338 |
Other Current Liabilities, Total | 45.558 | 46.821 | 16.5 | 16.151 | 9.4 |
Total Liabilities | 227.273 | 224.133 | 202.445 | 219.751 | 220.121 |
Total Long Term Debt | 61.25 | 61.319 | 66.41 | 66.751 | 71.834 |
Long Term Debt | 61.25 | 61.319 | 66.41 | 66.751 | 71.834 |
Other Liabilities, Total | 27.496 | 27.795 | 35.555 | 36.086 | 39.197 |
Total Equity | 111.862 | 102.414 | 96.86 | 92.265 | 105.303 |
Common Stock | 0.004 | 0.004 | 0.004 | 0.004 | 0.018 |
Additional Paid-In Capital | 532.02 | 531.636 | 530.689 | 529.831 | 528.686 |
Retained Earnings (Accumulated Deficit) | -420.162 | -429.226 | -433.833 | -437.57 | -423.401 |
Total Liabilities & Shareholders’ Equity | 339.135 | 326.547 | 299.305 | 312.016 | 325.424 |
Total Common Shares Outstanding | 45.3354 | 44.6404 | 44.6225 | 44.494 | 43.4359 |
Long Term Investments | 1.579 | 1.579 | 1.579 | 1.579 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netto indkomst/Startlinje | -1.281 | -28.144 | -217.201 | 36.908 | -102.496 |
Likvider Fra Driftsaktiviteter | 5.523 | -65.572 | 90.475 | 72.497 | 62.167 |
Likvider Fra Driftsaktiviteter | 29.077 | 26.431 | 102.946 | 106.426 | 105.502 |
Deferred Taxes | 0 | 0 | |||
Ikke-Likvide Ting | 9.02 | -19.647 | 205.336 | 36.361 | 40.823 |
Cash Taxes Paid | 0 | 1.136 | 4.401 | 6.472 | 0.121 |
Likvid Rente Betalt | 10.124 | 17.598 | 37.788 | 48.44 | 55.542 |
Ændringer i Driftskapital | -31.293 | -44.212 | -0.606 | -107.198 | 18.338 |
Likvider fra Investeringsaktiviteter | -18.525 | 512.801 | -1.481 | -7.082 | 57.894 |
Kapitaludgifter | -0.053 | -0.01 | -1.481 | -5.507 | -0.666 |
Andre Investerings-Cash-Flow-Ting, Total | -18.472 | 512.811 | 0 | -1.575 | 58.56 |
Likvider fra Financieringsaktiviteter | 29.026 | -468.55 | -157.836 | -81.35 | -110.886 |
Financiering af Cash-Flow-Ting | -6.193 | -4.382 | -8.087 | -0.87 | -9.826 |
Udstedelse (Pensionering) af Aktier, Netto | 45.054 | 0.088 | 0.251 | 2.02 | 8.94 |
Udstedelse (Pensionering) af Gæld, Netto | -9.835 | -464.256 | -150 | -82.5 | -110 |
Netto Ændring i Likviditet | 16.024 | -21.321 | -68.842 | -15.935 | 9.175 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 9.064 | -1.281 | -5.887 | -9.625 | 4.544 |
Cash From Operating Activities | 27.426 | 5.523 | 1.392 | -3.262 | -4.226 |
Cash From Operating Activities | 8.699 | 29.077 | 21.698 | 14.286 | 6.812 |
Non-Cash Items | 2.686 | 9.02 | 4.571 | 3.589 | 0.4 |
Cash Taxes Paid | -8.36 | 0 | 0 | 0 | 0 |
Cash Interest Paid | 0 | 10.124 | 5.216 | 5.216 | 0 |
Changes in Working Capital | 6.977 | -31.293 | -18.99 | -11.512 | -15.982 |
Cash From Investing Activities | -0.404 | -18.525 | 0 | 0 | 0 |
Capital Expenditures | -0.053 | 0 | 0 | 0 | |
Cash From Financing Activities | -2.443 | 29.026 | 36.548 | 36.904 | 44.473 |
Financing Cash Flow Items | -2.443 | -6.193 | -3.421 | -3.4 | -0.388 |
Issuance (Retirement) of Stock, Net | 0 | 45.054 | 45.054 | 45.054 | 44.861 |
Issuance (Retirement) of Debt, Net | -9.835 | -5.085 | -4.75 | 0 | |
Net Change in Cash | 24.579 | 16.024 | 37.94 | 33.642 | 40.247 |
Other Investing Cash Flow Items, Total | -0.404 | -18.472 | 0 | 0 |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.9481 | 2194270 | 82994 | 2022-12-31 | LOW |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 2.0623 | 1146213 | -430209 | 2022-12-31 | MED |
Bridgeway Capital Management, LLC | Investment Advisor | 1.7017 | 945800 | 150000 | 2022-12-31 | LOW |
Littlejohn & Co. LLC | Private Equity | 1.7015 | 945677 | 0 | 2022-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 1.6923 | 940574 | -108092 | 2022-12-31 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.6616 | 923478 | 40771 | 2022-12-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 1.5664 | 870598 | 579484 | 2022-12-31 | HIGH |
Renaissance Technologies LLC | Hedge Fund | 1.4893 | 827735 | 121200 | 2022-12-31 | HIGH |
Friess Associates LLC | Investment Advisor | 1.3794 | 766650 | -429802 | 2022-06-30 | |
First Eagle Investment Management, L.L.C. | Investment Advisor/Hedge Fund | 1.238 | 688075 | 188076 | 2022-12-31 | LOW |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.2029 | 668534 | -205846 | 2022-12-31 | HIGH |
D. E. Shaw & Co., L.P. | Hedge Fund | 0.9001 | 500252 | 21076 | 2022-12-31 | MED |
American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 0.8065 | 448219 | 179565 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7642 | 424731 | 8124 | 2022-12-31 | LOW |
Tekla Capital Management LLC | Investment Advisor | 0.7387 | 410575 | 0 | 2022-12-31 | LOW |
Perritt Capital Management, Inc. | Investment Advisor | 0.7313 | 406434 | 34334 | 2022-12-31 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.6667 | 370538 | -4283 | 2022-12-31 | LOW |
Peisert (Daniel A) | Individual Investor | 0.562 | 312364 | 153962 | 2023-02-11 | MED |
Citadel Advisors LLC | Hedge Fund | 0.5101 | 283507 | 907 | 2022-12-31 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 0.5076 | 282092 | -33340 | 2022-12-31 | MED |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group500K+
Handlende
92K+
Månedlkige, aktive klienter
$53M+
Månedlig investeringsvolumen
$30M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Assertio Holdings, Inc. Company profile
Om Assertio Holdings, Inc.
Assertio Holdings, Inc. er et specialiseret lægemiddelfirma, der tilbyder differentierede produkter til patienter ved hjælp af en ikke-personlig reklamemodel. Selskabets primære markedsførte produkter er INDOCIN (indometacin) suppositorier, INDOCIN (indometacin) oral suspension, INDOCIN (indometacin) oral suspension, CAMBIA (diclofenac kalium til oral opløsning), Otrexup (methotrexat) injektion til subkutan brug, SPRIX (ketorolac tromethamin) næsespray og Zipsor (diclofenac kalium) flydende fyldte kapsler. Selskabet har andre kommercielt tilgængelige produkter, herunder OXAYDO (oxycodone HCI, USP) tabletter udelukkende til oral brug. Assertio og Zyla er registrerede varemærker tilhørende selskabet. INDOCIN-produkterne anvendes til behandling af moderat til svær reumatoid arthritis, herunder akut opblussen af kronisk sygdom, moderat til svær ankyloserende spondylitis, moderat til svær artrose, akut smertefuld skulder (bursitis og/eller tendinitis) og akut gigtartritis.
Industry: | Pharmaceuticals (NEC) |
100 S. Saunders Road
Suite 300
60045
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com